Work

Defining immunological biomarkers for salivary gland carcinomas: First results from the prospective ImmoGlandula trial (NCT06047236)

Year: 2024

Type: conference-paper

Abstract: Background: Salivary gland carcinomas (SGC) are a rare tumor entity that comes along with a high heterogeneity in terms of the histological features, the dignity or the outcome. Therefore, the therapeutic options for SGCs are limited. The inclusion of immunotherapy (IT) however, might improve the outcome [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/24hnosw04

Authors: Donaubauer, Anna-Jasmina, Frey, Benjamin, Gaipl, Udo S., Fietkau, Rainer, Iro, Heinrich, Haderlein, Marlen, Müller, Sarina K.

Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen

Language: English

Topic: Salivary Gland Tumors Diagnosis and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6889973834

FWCI:

Cites:

Cited by:

Related to: